Abstract
Background
Cryoballoon ablation (CBA) is an established approach for rhythm management of atrial fibrillation (AF). We sought to assess balloon temperature (BT) parameters as predictors of pulmonary vein (PV) reconnection within the index procedure and AF recurrence following CBA.
Methods
BT was monitored in 119 AF patients undergoing CBA. PVs were assessed for reconnection during the procedure and patients were followed for arrhythmia recurrence.
Results
PV reconnection was identified in 39 (8.3%) of 471 PVs. BT was significantly colder in the absence of PV reconnection (30 s: − 33.5 °C [− 36; − 30] vs − 29.5 °C [− 35; − 25.5], p = 0.001; 60 s: − 41 °C [− 44; − 37] vs − 36.5 °C [− 42; − 33.5], p < 0.001; nadir: − 47 °C [− 52; − 43] vs − 41.5 °C [− 47; − 38], p < 0.001). PV reconnection was associated with significantly longer time to reach − 15 °C and – 40 °C (14.5 s [11.5–18.5] vs 12 s [10–15.5], p = 0.023; and 75 s [40–95.5] vs 46 s [37–66.75], p = 0.005) and shorter rewarming time (5.75 s [4.75–8.5] vs 7 s [6–9], p = 0.012). ROC analysis of these procedural parameters had an AUC = 0.71 in predicting PV reconnection. AF recurrence occurred in 51 (42.8%) patients. Kaplan–Meier analysis showed better arrhythmia-free survival for patients in whom BT decreased below – 40 °C in all PVs and patients who had no early PV reconnections, compared to patients in whom BT below – 40 °C was not achieved in at least one PV (log rank = 6.3, p = 0.012) and patients who had PV reconnections (log rank = 4.1, p = 0.043).
Conclusions
Slower BT decline, warmer BT nadir, and faster rewarming time predict early PV reconnection. Absence of early PV reconnections and BT dropping below – 40 °C in all PVs during CBA are associated with lower rates of AF recurrence.
Similar content being viewed by others
References
Stabile G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27(2):216–21. https://doi.org/10.1093/EURHEARTJ/EHI583.
Packer DL, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American arctic front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–23. https://doi.org/10.1016/j.jacc.2012.11.064.
Wilber DJ, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333–40. https://doi.org/10.1001/JAMA.2009.2029.
Pappone C, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006;48(11):2340–7. https://doi.org/10.1016/J.JACC.2006.08.037.
Jaïs P, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498–505. https://doi.org/10.1161/CIRCULATIONAHA.108.772582.
Kuck KH, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):393–4. https://doi.org/10.1056/NEJMOA1602014.
Andrade JG, Khairy P, Dubuc M. Catheter cryoablation: biology and clinical uses. Circ Arrhythm Electrophysiol. 2013;6(1):218–27. https://doi.org/10.1161/CIRCEP.112.973651.
Khairy P, Dubuc M. Transcatheter cryoablation part I: preclinical experience. Pacing Clin Electrophysiol. 2008;31(1):112–20. https://doi.org/10.1111/J.1540-8159.2007.00934.X.
Khairy P, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation. 2003;107(15):2045–50. https://doi.org/10.1161/01.CIR.0000058706.82623.A1.
K. R. J. Chun et al., “The impact of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation on healthcare utilization and costs: an economic analysis from the FIRE AND ICE trial,” J Am Heart Assoc 2017;6 8. https://doi.org/10.1161/JAHA.117.006043
P. A. Harris et al., “The REDCap consortium: building an international community of software platform partners,” J Biomed Inform, 2019;95. https://doi.org/10.1016/J.JBI.2019.103208
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. https://doi.org/10.1016/J.JBI.2008.08.010.
Calkins H, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Hear Rhythm. 2017;14(10):e275–444. https://doi.org/10.1016/J.HRTHM.2017.05.012.
Andrade JG, et al. Cryoballoon ablation as initial treatment for atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78(9):914–30. https://doi.org/10.1016/J.JACC.2021.06.038.
Ciconte G, et al. Spontaneous and adenosine-induced pulmonary vein reconnection after cryoballoon ablation with the second-generation device. J Cardiovasc Electrophysiol. 2014;25(8):845–51. https://doi.org/10.1111/jce.12421.
Deubner N, et al. The slope of the initial temperature drop predicts acute pulmonary vein isolation using the second-generation cryoballoon. Europace. 2017;19(9):1470–7. https://doi.org/10.1093/EUROPACE/EUW192.
Keçe F, et al. Predicting early reconnection after cryoballoon ablation with procedural and biophysical parameters. Hear Rhythm 02. 2021;2(3):290–7. https://doi.org/10.1016/J.HROO.2021.03.007.
Aryana A, et al. Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation. Hear Rhythm. 2016;13(2):424–32. https://doi.org/10.1016/J.HRTHM.2015.10.033.
Chun KRJ, et al. Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial. Hear Rhythm. 2017;14(4):495–500. https://doi.org/10.1016/J.HRTHM.2016.12.014.
Efremidis M, et al. Early pulmonary vein reconnection as a predictor of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2015;17(5):741–6. https://doi.org/10.1093/EUROPACE/EUU216.
Knecht S, et al. Anatomical predictors for acute and mid-term success of cryoballoon ablation of atrial fibrillation using the 28 mm balloon. J Cardiovasc Electrophysiol. 2013;24(2):132–8. https://doi.org/10.1111/JCE.12003.
Acknowledgements
We acknowledge the tremendous support of the Division of Cardiology Section of Electrophysiology and the Department of Bioengineering at the University of Washington.
Funding
This work was supported by the John Locke Charitable Trust to NA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Access to patient information was approved by the Institutional Review Board (IRB) of the University of Washington.
Informed consent
All participants provided verbal consent (HSD#6058) for use of their anonymized clinical data for research purposes.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chahine, Y., Afroze, T., Bifulco, S.F. et al. Cryoballoon temperature parameters during cryoballoon ablation predict pulmonary vein reconnection and atrial fibrillation recurrence. J Interv Card Electrophysiol 66, 1367–1373 (2023). https://doi.org/10.1007/s10840-022-01429-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-022-01429-0